COMMUNIQUÉS West-GlobeNewswire

-
Neos Therapeutics Announces Pricing of Underwritten Public Offering of $40 Million of Common Stock
06/11/2018 - 15:21 -
Obalon Announces Upcoming Conference Presentations
06/11/2018 - 15:15 -
How to Invest in Cannabis Beverages -- CFN Media
06/11/2018 - 15:00 -
Physeon Receives Institutional Review Board Approval to Commence US “VIVA” Trial for Veinplicity at Second Site
06/11/2018 - 15:00 -
NewLink Genetics Announces Publication of Abstracts for Presentation at the Society for Immunotherapy for Cancer (SITC) Conference
06/11/2018 - 15:00 -
Oncobiologics Advances ONS-5010 into wet AMD Clinical Trial
06/11/2018 - 15:00 -
Rolling Strong Announces Partnership with eTrueNorth
06/11/2018 - 15:00 -
Rafael Pharmaceuticals Appoints Vice President, Manufacturing and CMC Regulatory Affairs and Vice President of Regulatory Affairs to Strengthen Development of CPI-613
06/11/2018 - 14:55 -
Dr. Sheldon Marks Authors Definitive Medical Textbook on Vasectomy Reversal
06/11/2018 - 14:45 -
Crown Bioscience to Showcase Scientific Expertise at the EORTC-NCI-AACR
06/11/2018 - 14:40 -
Marrone Bio Innovations Announces International Distribution Partnership with Agricultural Materials Company (AMC-TR) in Turkey
06/11/2018 - 14:31 -
Insmed to Present at Three November Conferences
06/11/2018 - 14:30 -
Albireo to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 13, 2018
06/11/2018 - 14:30 -
The Crucial Role of Genetics in the Future of the Cannabis Industry -- CFN Media
06/11/2018 - 14:30 -
ATW Tech Announces Signature of a Letter of Intent for Major Acquisition of Greywolf Entertainment Group
06/11/2018 - 14:30 -
ATW Tech annonce la signature d’une lettre d’intention pour l’acquisition majeure du Groupe Greywolf Entertainment
06/11/2018 - 14:30 -
Vaccinex, Inc. to Present Data on Its Semaphorin 4D Monoclonal Antibody Programs at Two Conferences Focused on Cancer Immunotherapy and Huntington’s Disease
06/11/2018 - 14:30 -
Early Cannabis Legalization Struggles Could Yield Opportunities -- CFN Media
06/11/2018 - 14:30 -
Assure Holdings Sets Third Quarter 2018 Conference Call for Tuesday, November 27, 2018, at 4:30 p.m. ET
06/11/2018 - 14:30
Pages